seperator

About Ethris

seperator

 

seperator

About Ethris

seperator

 

A SHORT INTRODUCTION

Based in the biotech hub of Martinsried just outside Munich, Germany, Ethris was founded by Dr. Carsten Rudolph and Prof. Christian Plank in 2009. The company has established a number of strategic partnerships both with leading academic and medical institutions in Germany and abroad, and with corporate biotechnology and pharmaceutical companies around the globe.

The potential applications of messenger RNA-based therapies are too numerous for a single company to pursue. As a result, Ethris is focused internally on a strategic set of metabolic and respiratory disorders, and works with partners to realize the potential for its patented SNIM®RNA Transcript Therapies in other areas of human disease. Learn more about our technology.

ETHRIS IS PAVING A NEW PATH FROM GENES TO THERAPEUTIC PROTEINS USING OUR PROPRIETARY MESSENGER RNA TECHNOLOGY.

ETHRIS IS PAVING A NEW PATH FROM GENES TO THERAPEUTIC PROTEINS USING OUR PROPRIETARY MESSENGER RNA TECHNOLOGY.

READ MORE

Get in touch.

CONTACT